This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionSEC Recommends Phase III Trial of MSN Labs' Vibegron Against Mirabegron in Overactive Bladder
Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan ConcernsHealth crisis in a bottle: Rajasthan govt bans cough syrup batch after patients fall ill in...
Khadgawan CHC Honoured with ISO Certification for Vaccine Storage StandardsNot All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections
Misclassifying Drugs as NutraceuticalsFake docs, real jobs: Pharmacist at Community Health Centre in Ballia booked in recruitment scam
Wockhardt posts profit of Rs 82 crore in Q2Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative...
Biocon, BahiaFarma, Bionovis Ink MoU to Co-Develop Breast Cancer TherapyBiocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US
USFDA Approves Bionpharmas Generic HIV Drug EtravirineLupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric...
Pharma Firm Slapped Rs 15 Lakh for Infringing IPCAs ZERODOL TrademarkBombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms
Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claimsIndian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR
Drug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual HikeRajasthan Drug Official Under Probe for Misreporting Spurious Medicines
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial ProtocolIntas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter MarketAbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels
X